Information Journal Paper
APA:
CopyNorouzi Barough, Leyla, Sarookhani, Mohammadreza, SALEHI, RASOUL, SHARIFI, MOHAMMADREZA, & MOGHBELINEJAD, SAHAR. (2018). CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 21(2), 181-187. SID. https://sid.ir/paper/721876/en
Vancouver:
CopyNorouzi Barough Leyla, Sarookhani Mohammadreza, SALEHI RASOUL, SHARIFI MOHAMMADREZA, MOGHBELINEJAD SAHAR. CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES[Internet]. 2018;21(2):181-187. Available from: https://sid.ir/paper/721876/en
IEEE:
CopyLeyla Norouzi Barough, Mohammadreza Sarookhani, RASOUL SALEHI, MOHAMMADREZA SHARIFI, and SAHAR MOGHBELINEJAD, “CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line,” IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, vol. 21, no. 2, pp. 181–187, 2018, [Online]. Available: https://sid.ir/paper/721876/en